Delivery Order SPE2DR25D3401-SPE2DR26FL0AH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Risperidone 2 mg tablets in quantities of 60 units at a firm fixed price of $2,213.75. The contract carries an ultimate completion date of July 17, 2025, and represents a non-set-aside, competitively awarded procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Risperidone 0.5 mg tablets (60-count) with a firm fixed price ceiling value of $6,580.29. The order was competitively awarded with no set-aside designation and carries an ultimate completion date of September 4, 2025. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Risperidone 0.5 mg tablets in quantities of 60 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,682.34 and represents a firm fixed-price delivery order with an ultimate completion date of November 19, 2025. The pharmaceutical product will be sourced from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for Risperidone 1 mg ODT (orally disintegrating tablet) in unit dose packaging, 30-count quantities. This is a firm fixed-price delivery order with a ceiling value of $1,780.96 and an ultimate completion date of July 22, 2025. The contract is non-set-aside and represents a competitive award. Performance will take place at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,054.47 to AmerisourceBergen Drug Corp for the supply of Risperidone 2 mg tablets in quantities of 60 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on April 24, 2025, with an ultimate completion date of April 25, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.86 to AmerisourceBergen Drug Corp for 500 tablets of Risperidone 0.25 mg. This contract, issued on June 20, 2025, with an ultimate completion date of June 23, 2025, is a firm fixed price delivery order with no set-aside designation. The award reflects a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, designated as SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Risperidone 2 mg tablets in quantities of 60 units. This firm fixed-price delivery order carries a ceiling value of $2,620.44 and is scheduled for completion by October 21, 2025. The contract represents a non-competitive award under an existing indefinite delivery contract vehicle, with performance occurring at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,004.16 to AmerisourceBergen Drug Corp for the supply of Risperdal (risperidone) 2 mg tablets in a 60-count package. This competitively awarded, non-set-aside firm fixed price delivery order was issued on September 5, 2025, with an ultimate completion date of September 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Risperidone 0.5 mg tablets in a 60-count quantity, with a ceiling value of $1,310.34. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Risperidone 2 mg tablets in quantities of 60 units. This is a firm fixed-price delivery order with a ceiling value of $1,965.54 and an ultimate completion date of October 20, 2025. The contract was awarded without set-aside provisions through competitive procurement, and the place of performance is located in Conshohocken, Pennsylvania, which is...
- SPE2DR25D3401Indefinite Delivery Contract
- SPE2DR25D3401-SPE2DR26FL0AHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Risperidone 2 mg tablets in quantities of 60 units, with a contract ceiling value of $1,484.52. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is set for ultimate completion by November 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026 that supports comprehensive pharmaceutical supply needs for military healthcare systems globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency, military, and veteran healthcare systems. The company's substantial IDC with DLA enables it to supply an extensive portfolio of pharmaceutical products across multiple therapeutic domains, including brand-name and generic medications, vaccines, and specialized medical supplies. This specific delivery order for Risperidone, an antipsychotic medication, exemplifies the company's role in fulfilling routine pharmaceutical requirements for the federal healthcare supply chain through DLA's flexible contracting mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 11/18/25 |